← All stories
Markets
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
Dual-action eye drop targeting both evaporative and inflammatory dry eye disease moving to Phase 3 Positive Phase 1b results for ocular surface pain candidate validate TRPV1 antagonist approach and strengthen confidence in ongoing Phase 2 s…
Covered by 1 outlet
All coverage · 1 article